Ultra-early versus early adjunctive vasopressin initiation after norepinephrine escalation in septic shock: a target trial emulation
Intensive Care Medicine · 2026-10 · 52 (10) · 2085-2095
DOI: 10.1007/s00134-026-08575-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intensive Care Medicine, online erschienen am 11.08.2026. Verfasst von Takaya Nakashima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. a82282008@gmai…. Hauptthemen laut MEDLINE: Shock, Septic, Norepinephrine, Vasopressins, Vasoconstrictor Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
PURPOSE: The optimal timing of adjunctive vasopressin after norepinephrine escalation in septic shock remains uncertain. We emulated a target trial comparing ultra-early vasopressin initiation within 0-3 h with early initiation within > 3-6 h after the norepinephrine infusion rate reached 0.25 μg/kg/min or higher. METHODS: We emulated a target trial using electronic health record databases (MIMIC-IV 2008-2022 and eICU-CRD 2014-2015). Adults with septic shock who reached the norepinephrine threshold before vasopressin use were eligible. We used the clone-censor-weight method to estimate cumulative incidence curves under the ultra-early and early initiation strategies and compared them via the weighted Cox model. RESULTS: Among 3810 eligible patients, after cloning, 744 clones adhered to the ultra-early strategy and 293 clones adhered to the early strategy. The weighted 28-day mortality risk was 48.1% under the ultra-early strategy and 53.0% under the early strategy (risk difference, - 5.0 percentage points; 95% confidence interval [CI] - 6.8 to - 3.2), with a restricted mean survival time difference of 1.58 days (95% CI 1.21-1.92) and a hazard ratio (HR) of 0.82 (95% CI 0.78-0.85). Ultra-early initiation was associated with lower renal replacement therapy (HR, 0.68; 95% CI 0.63-0.74), continuous renal replacement therapy (HR, 0.61; 95% CI 0.55-0.68), and medically treated arrhythmia (HR, 0.91; 95% CI 0.83-0.99), but not with lower acute kidney injury. CONCLUSIONS: Among adults with septic shock whose norepinephrine infusion reached 0.25 μg/kg/min or higher before vasopressin use, vasopressin initiation within 0-3 h was associated with lower 28-day mortality than initiation within > 3-6 h.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. a82282008@gmail.com.
- Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan. a82282008@gmail.com.
- TXP Medical Co. Ltd, Tokyo, Japan. a82282008@gmail.com.
- Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Emergency and Critical Care Center, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
- Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan.
Zitieren
APA
Nakashima, T., Ichinomiya, T., Nakajima, M., Shinozaki, T., Shibata, J., Goto, T., Sato, S., & Hara, T. (2026). Ultra-early versus early adjunctive vasopressin initiation after norepinephrine escalation in septic shock: a target trial emulation. Intensive Care Medicine, 52(10), 2085-2095. https://doi.org/10.1007/s00134-026-08575-3
Vancouver
Nakashima T, Ichinomiya T, Nakajima M, Shinozaki T, Shibata J, Goto T, et al. Ultra-early versus early adjunctive vasopressin initiation after norepinephrine escalation in septic shock: a target trial emulation. Intensive Care Medicine. 2026;52(10):2085-2095. doi:10.1007/s00134-026-08575-3
BibTeX
@article{Nakashima2026,
author = {Nakashima, Takaya and Ichinomiya, Taiga and Nakajima, Mikio and Shinozaki, Tomohiro and Shibata, Junichiro and Goto, Tadahiro and Sato, Shuntaro and Hara, Tetsuya},
title = {Ultra-early versus early adjunctive vasopressin initiation after norepinephrine escalation in septic shock: a target trial emulation},
journal = {Intensive Care Medicine},
year = {2026},
volume = {52},
number = {10},
pages = {2085--2095},
doi = {10.1007/s00134-026-08575-3}
}
EUVIMED